Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback on this new experience.Tell us what you think(opens in new tab/window)

Elsevier
Publish with us

Thomas Carell

TC

Thomas Carell

Ludwig Maximilians University, Germany

Thomas Carell moved to the ETH Zürich (Switzerland) as an assistant professor to start independent research. He obtained his habilitation (tenure) in 2000. He subsequently accepted a full professor position for Organic Chemistry at the Philipps-Universität in Marburg (Germany). In 2004 Thomas Carell moved to the Ludwig-Maximilians-Universität (LMU) in Munich (Germany), where he is heading a research group centered around chemical biology. The current focus is to analyze the chemistry of epigenetic programming in DNA and RNA. Thomas Carell founded the company Baseclick GmBH in 2008. He is a member of the National German Academy, Leopoldina and of the Berlin-Brandenburg Academy of Arts and Sciences. He is a recipient of the Cross of Merit from the Federal Republic of Germany (knighted). Thomas Carell obtained the Leibniz award from the DFG in 2003 (comparable to an HHMI investigator in the USA) and an ERC advanced grant in 2017. Thomas Carell is the speaker of the collaborative research center (CRC1309) on chemical epigenetics. He is the founder of the company Baseclick GmbH and since 2019 he is a member of the supervisory board at BASF SE.